Home » Stocks » FLGT

Fulgent Genetics, Inc. (FLGT)

Stock Price: $91.92 USD -3.31 (-3.48%)
Updated Jul 29, 2021 4:00 PM EDT - Market closed
After-hours: $90.93 -0.99 (-1.08%) Jul 29, 7:57 PM
Market Cap 2.76B
Revenue (ttm) 773.39M
Net Income (ttm) 416.96M
Shares Out 28.83M
EPS (ttm) 15.82
PE Ratio 5.81
Forward PE 7.41
Dividend n/a
Dividend Yield n/a
Trading Day July 29
Last Price $91.92
Previous Close $95.23
Change ($) -3.31
Change (%) -3.48%
Day's Open 95.14
Day's Range 90.08 - 95.69
Day's Volume 613,322
52-Week Range 25.03 - 189.89

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

It may be curtains for the apes' high-profile, most-shorted stocks, but others may become the real deal with other bullish investors. The post 3 Smaller Most-Shorted Stocks to Buy appeared first on Inve...

Other stocks mentioned: FUBO, TTCF
3 days ago - InvestorPlace

TEMPLE CITY, Calif.--(BUSINESS WIRE)---- $FLGT--In the headline and first paragraph, first sentence of release, the date should read: Monday, August 9, 2021 (instead of Thursday, August 5, 2021). The up...

3 days ago - Business Wire

TEMPLE CITY, Calif.--(BUSINESS WIRE)---- $FLGT--Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”), a technology company providing comprehensive testing solutions through its sc...

3 days ago - Business Wire

The stock has traded with the ebbs and flows of COVID cases, but its testing has consistently delivered for its impressive list of customers.

1 week ago - The Motley Fool

Few companies had bigger tailwinds from COVID-19. What comes next could be even more exciting.

2 weeks ago - The Motley Fool

Despite easing restrictions, COVID is going to be around a lot longer than many think.

Other stocks mentioned: ABT, BNTX, LHDX, RHHBY
2 weeks ago - The Motley Fool

A steep sell-off is required for these stocks to become bargain buys.

Other stocks mentioned: ROKU, TTWO
2 weeks ago - The Motley Fool

FULGENT GENETIC (FLGT) closed the most recent trading day at $85.94, moving -0.13% from the previous trading session.

2 weeks ago - Zacks Investment Research

Investors are seeking out the most highly shorted stocks. With GME and AMC seeing monolithic gains, can the same thing be done elsewhere?

Other stocks mentioned: ACI, AGC, BLNK, CLOV, ESPR, FUV, GOEV ...
3 weeks ago - InvestorPlace

FULGENT GENETIC (FLGT) closed at $87.17 in the latest trading session, marking a -0.31% move from the prior day.

3 weeks ago - Zacks Investment Research

All is not lost for this COVID-19 testing company.

1 month ago - The Motley Fool

FULGENT GENETIC (FLGT) closed at $83.53 in the latest trading session, marking a +1.17% move from the prior day.

1 month ago - Zacks Investment Research

Ongoing COVID-19 testing and deals in the core business could keep growth high for longer than many think.

1 month ago - The Motley Fool

High-growth stocks aren't bothered by inflation like their big-cap brethren. Here are some high-risk stocks with plenty to offer investors.

Other stocks mentioned: ATY, AVNW, BGFV, EXPR, HOME, KIRK, ZDGE
1 month ago - InvestorPlace

In the latest trading session, FULGENT GENETIC (FLGT) closed at $75.69, marking a +1.16% move from the previous day.

1 month ago - Zacks Investment Research

As we kicked off 2021, we highlighted two top contrarian picks for the new year.

1 month ago - Schaeffers Research

These seven healthcare stocks are in a good position to take off as baby boomers continue to age into retirement. The post 7 Healthcare Stocks to Buy for Changing Demographics appeared first on Investor...

Other stocks mentioned: AMEH, HCA, JYNT, LH, SGRY, THC
1 month ago - InvestorPlace

Wall Street is nervous, but these companies see growth beyond the pandemic.

Other stocks mentioned: TDOC
1 month ago - The Motley Fool

Traders often look at short interest to get a sense of how many people are bearish on a stock and how strong the possibility of a short squeeze is. But simply looking at the size of the outstanding shor...

Other stocks mentioned: BBBY, DMTK, ESPR, GEO, GTT, IGMS, WKHS
1 month ago - Benzinga

Genetic testing for the coronavirus is slowing.

2 months ago - The Motley Fool

Hint: It has something to do with COVID-19.

2 months ago - The Motley Fool

TEMPLE CITY, Calif.--(BUSINESS WIRE)--Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “Company”), a technology company providing comprehensive testing solutions through its scalable tec...

2 months ago - Business Wire

More than 4,500% revenue growth gave Wall Street and shareholders something to cheer about.

2 months ago - The Motley Fool

FULGENT GENETIC (FLGT) delivered earnings and revenue surprises of 10.02% and 13.35%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

2 months ago - Zacks Investment Research

FULGENT GENETIC (FLGT) closed the most recent trading day at $73.01, moving +1.61% from the previous trading session.

2 months ago - Zacks Investment Research

TEMPLE CITY, Calif.--(BUSINESS WIRE)--Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent” or the “company”), a technology company providing large-scale COVID-19 testing services and comprehensive testing s...

2 months ago - Business Wire

TEMPLE CITY, Calif.--(BUSINESS WIRE)---- $FLGT--Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “Company”), a technology company providing comprehensive testing solutions through its sc...

2 months ago - Business Wire

Good news for the U.S. has been bad news for shareholders.

2 months ago - The Motley Fool

COVID-19 testing and NGS-based testing solutions are expected to have contributed to Fulgent Genetics' (FLGT) Q1 earnings.

2 months ago - Zacks Investment Research

FULGENT GENETIC (FLGT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

3 months ago - Zacks Investment Research

FULGENT GENETIC (FLGT) closed at $87.64 in the latest trading session, marking a +0.52% move from the prior day.

3 months ago - Zacks Investment Research

The genetic testing giant's journey resembles the path of past winners.

3 months ago - The Motley Fool

The government is going to invest heavily in COVID-19 research and tracking, and these companies are likely to benefit.

Other stocks mentioned: ILMN, TXG
3 months ago - The Motley Fool

FULGENT GENETIC (FLGT) closed at $86.78 in the latest trading session, marking a -0.99% move from the prior day.

3 months ago - Zacks Investment Research

If you are screening the market for high-return investments, you may want to consider the three non-cyclical stocks listed below, as their earnings yields (as calculated via Joel Greenblatt (Trades, Por...

Other stocks mentioned: ENIA, VIVO
3 months ago - GuruFocus

Less COVID-19 testing means less revenue for some companies.

Other stocks mentioned: ABT, BDX, QDEL
3 months ago - The Motley Fool

Be wary of companies posting abnormal growth rates.

Other stocks mentioned: COIN
3 months ago - The Motley Fool

He also gave clues that point to a few possible targets.

3 months ago - The Motley Fool

If you want to enhance your likelihood to beat the market, one method is to select stocks that rank highly according to the "Magic Formula" criteria.

Other stocks mentioned: BDSI, BPMC
3 months ago - GuruFocus

Growth last year was awesome, but there is something to be even more excited about.

3 months ago - The Motley Fool

TEMPLE CITY, Calif., April 16, 2021 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”), a technology company providing comprehensive testing solutions throug...

3 months ago - GlobeNewsWire

In the latest trading session, FULGENT GENETIC (FLGT) closed at $88.95, marking a +1.37% move from the previous day.

3 months ago - Zacks Investment Research

They've underperformed the S&P 500 in the past month, but these stocks show lots of potential over the long term.

Other stocks mentioned: VIA
3 months ago - The Motley Fool

Recent advances in computer technology have lit a fuse under the genomic sequencing industry. And here's what investors need to know now.

3 months ago - InvestorPlace

FULGENT GENETIC (FLGT) closed at $85.24 in the latest trading session, marking a -0.42% move from the prior day.

3 months ago - Zacks Investment Research

A rebounding economy is a good time to thaw out your risk capital and start buying some high-risk stocks with long-term potential. The post 8 High-Risk Stocks to Buy That Are Worth Taking A Chance On ap...

Other stocks mentioned: AMRS, DCP, EXPI, FUTU, MIK, SI, SPWR
3 months ago - InvestorPlace

Industry trends could support massive gains for shareholders over the next 10 years.

Other stocks mentioned: NARI, TDOC
3 months ago - The Motley Fool

We have narrowed down our search to the following stocks, FLGT, BIO and IDXX based on a favorable Zacks Rank and strong prospects for 2021.

Other stocks mentioned: ABT, BDX, BIO, DGX, IDXX
3 months ago - Zacks Investment Research

Shareholders could be big winners if the demand for COVID-19 testing lingers.

3 months ago - The Motley Fool

Investors seeking a multi-year growth opportunity should watch out for these three stocks.

Other stocks mentioned: DDOG, SQ
3 months ago - The Motley Fool

About FLGT

Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19 testing and genetic testing services to physicians with clinically actionable diagnostic information. Its technology platform integrates data comparison and suppression algorithms, adaptive learning software, and genetic diagnostics tools and integrated laboratory processes. The company primarily serves insurance, hospitals, and medical institutions. It sells its tests through internal sales force, as well as through independent sales representatives in the United States ... [Read more...]

Industry
Diagnostics & Research
IPO Date
Sep 29, 2016
CEO
Ming Hsieh
Employees
700
Stock Exchange
NASDAQ
Ticker Symbol
FLGT
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecasts

According to 4 analysts, the average rating for FLGT stock is "Buy." The 12-month stock price forecast is 87.00, which is a decrease of -5.35% from the latest price.

Price Target
$87.00
(-5.35% downside)
Analyst Consensus: Buy